» Articles » PMID: 39006018

Risk Factors of Bloodstream Infection in Erythroderma from Atopic Dermatitis, Psoriasis, and Drug Reactions: a Retrospective Observational Cohort Study

Overview
Journal PeerJ
Date 2024 Jul 15
PMID 39006018
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Atopic dermatitis (AD), psoriasis, and drug reactions associated with erythroderma are frequently complicated by infections. However, bloodstream infection (BSI) have received less research attention.

Objectives: This study aimed to investigate the clinical characteristics and risk factors associated with BSI in patients with erythroderma.

Methods: A retrospective analysis was conducted on 141 erythroderma cases. Eleven cases were identified as having BSI. Clinical records of both BSI and non-BSI groups were reviewed and compared.

Results: BSI was diagnosed in 7.80% (11/141) of erythroderma cases, with a breakdown of 7.14% in AD, 2.00% in psoriasis, and 17.14% in drug reactions. Notably, all positive skin cultures (7/7) showed bacterial isolates concordant with blood cultures. Univariate logistic regression analysis revealed several significant associations with BSI, including temperature (≤36.0 or ≥38.5 °C; odds ratio (OR) = 28.06; < 0.001), chilling (OR = 22.10; < 0.001), kidney disease (OR = 14.64; < 0.001), etiology of drug reactions (OR = 4.18; = 0.03), albumin (ALB) (OR = 0.86; < 0.01), C-reaction protein (CRP) (OR = 1.01; = 0.02), interleukin 6 (IL-6) (OR = 1.02; = 0.02), and procalcitonin (PCT) (OR = 1.07; = 0.03). Receiver operating characteristic (ROC) curves demonstrated significant associations with ALB ( < 0.001; the area under curve (AUC) = 0.80), PCT ( = 0.009; AUC = 0.74), and CRP ( = 0.02; AUC = 0.71).

Conclusions: Increased awareness of BSI risk is essential in erythroderma management. Patients with specific risk factors, such as abnormal body temperature (≤36.0 or ≥38.5 °C), chilling sensations, kidney disease, a history of drug reactions, elevated CRP (≥32 mg/L), elevated PCT (≥1.00 ng/ml), and low albumin (≤31.0 g/L), require close monitoring for BSI development.

References
1.
Chao W, Wang C, Hsu B, Lin C, Huang W, Chen Y . Factors associated with sepsis risk in immune-mediated inflammatory diseases receiving tumor necrosis factor inhibitors: a nationwide study. Ther Adv Musculoskelet Dis. 2020; 12:1759720X20929208. PMC: 7298427. DOI: 10.1177/1759720X20929208. View

2.
Doerflinger M, Haeusler G, Li-Wai-Suen C, Clark J, Slavin M, Babl F . Procalcitonin and Interleukin-10 May Assist in Early Prediction of Bacteraemia in Children With Cancer and Febrile Neutropenia. Front Immunol. 2021; 12:641879. PMC: 8173204. DOI: 10.3389/fimmu.2021.641879. View

3.
Kern W, Rieg S . Burden of bacterial bloodstream infection-a brief update on epidemiology and significance of multidrug-resistant pathogens. Clin Microbiol Infect. 2019; 26(2):151-157. DOI: 10.1016/j.cmi.2019.10.031. View

4.
Kleinschmidt S, Huygens F, Faoagali J, Rathnayake I, Hafner L . Staphylococcus epidermidis as a cause of bacteremia. Future Microbiol. 2015; 10(11):1859-79. DOI: 10.2217/fmb.15.98. View

5.
Drinka P, Bonham P, Crnich C . Swab culture of purulent skin infection to detect infection or colonization with antibiotic-resistant bacteria. J Am Med Dir Assoc. 2011; 13(1):75-9. DOI: 10.1016/j.jamda.2011.04.012. View